Armistice Capital, LLC 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:44 pm Sale |
2024-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 2,207,070 3.880% |
-1,316,930 (-37.37%) |
Filing |
| 2024-02-14 2:21 pm Purchase |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 3,524,000 6.310% |
774,000 (+28.15%) |
Filing |
| 2023-02-14 11:54 am Purchase |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 2,750,000 5.010% |
2,750,000 (New Position) |
Filing |